BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hegelmaier T, Lebbing M, Duscha A, Tomaske L, Tönges L, Holm JB, Bjørn Nielsen H, Gatermann SG, Przuntek H, Haghikia A. Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson's Disease. Cells 2020;9:E376. [PMID: 32041265 DOI: 10.3390/cells9020376] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Lorente-Picón M, Laguna A. New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota. Biomolecules 2021;11:433. [PMID: 33804226 DOI: 10.3390/biom11030433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Clin Microbiol Rev 2022;:e0033820. [PMID: 34985325 DOI: 10.1128/CMR.00338-20] [Reference Citation Analysis]
3 Baizabal-Carvallo JF, Alonso-Juarez M, Fekete R. Intestinal Decontamination Therapy for Dyskinesia and Motor Fluctuations in Parkinson's Disease. Front Neurol 2021;12:729961. [PMID: 34566874 DOI: 10.3389/fneur.2021.729961] [Reference Citation Analysis]
4 Fonseca Cabral G, Schaan AP, Cavalcante GC, Sena-Dos-Santos C, de Souza TP, Souza Port's NM, Dos Santos Pinheiro JA, Ribeiro-Dos-Santos Â, Vidal AF. Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinson's Disease. Int J Mol Sci 2021;22:9839. [PMID: 34576000 DOI: 10.3390/ijms22189839] [Reference Citation Analysis]
5 Brown EG, Goldman SM. Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond. Neurotherapeutics 2020;17:1406-17. [PMID: 33034846 DOI: 10.1007/s13311-020-00942-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Gallop A, Weagley J, Paracha SU, Grossberg G. The Role of The Gut Microbiome in Parkinson's Disease. J Geriatr Psychiatry Neurol 2021;34:253-62. [PMID: 34219519 DOI: 10.1177/08919887211018268] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Gentile F, Doneddu PE, Riva N, Nobile-Orazio E, Quattrini A. Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration. Int J Mol Sci 2020;21:E7471. [PMID: 33050475 DOI: 10.3390/ijms21207471] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
8 Plassais J, Gbikpi-Benissan G, Figarol M, Scheperjans F, Gorochov G, Derkinderen P, Cervino ACL. Gut microbiome alpha-diversity is not a marker of Parkinson's disease and multiple sclerosis. Brain Commun 2021;3:fcab113. [PMID: 34704023 DOI: 10.1093/braincomms/fcab113] [Reference Citation Analysis]
9 Spichak S, Bastiaanssen TFS, Berding K, Vlckova K, Clarke G, Dinan TG, Cryan JF. Mining microbes for mental health: Determining the role of microbial metabolic pathways in human brain health and disease. Neurosci Biobehav Rev 2021;125:698-761. [PMID: 33675857 DOI: 10.1016/j.neubiorev.2021.02.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
10 Socała K, Doboszewska U, Szopa A, Serefko A, Włodarczyk M, Zielińska A, Poleszak E, Fichna J, Wlaź P. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res 2021;172:105840. [PMID: 34450312 DOI: 10.1016/j.phrs.2021.105840] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Lerner A. The intestinal luminal sources of α-synuclein: a gastroenterologist perspective. Nutr Rev 2021:nuab024. [PMID: 33942062 DOI: 10.1093/nutrit/nuab024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Nielsen SD, Pearson NM, Seidler K. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport. Brain Res 2021;1769:147609. [PMID: 34371014 DOI: 10.1016/j.brainres.2021.147609] [Reference Citation Analysis]
13 Gorecki AM, Dunlop SA, Rodger J, Anderton RS. The gut-brain axis and gut inflammation in Parkinson's disease: stopping neurodegeneration at the toll gate. Expert Opin Ther Targets 2020;24:601-4. [PMID: 32349553 DOI: 10.1080/14728222.2020.1763956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Tan LY, Yeo XY, Bae HG, Lee DPS, Ho RC, Kim JE, Jo DG, Jung S. Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases? Life (Basel) 2021;11:698. [PMID: 34357070 DOI: 10.3390/life11070698] [Reference Citation Analysis]